Avidity Partners Management LP Quant / Systematic

Location: Dallas, TX

CIK: 0001791827 · Show all filings

Period: Q4 2019 (Next →)

Filing Date: Jun 17, 2020

Total Value: $159M (100.0% shares, 0.0% debt)

Holdings (33)

BAX BAXTER INTL INC 8.7%

Value $13.8M Shares 165,000 Est. Cost $73.38 Unrealized 0.0%

HCA HCA HEALTHCARE INC 5.8%

Value $9.268M Shares 62,700 Est. Cost $127.66 Unrealized 0.0%

VRTX VERTEX PHARMACEUTICALS INC 5.5%

Value $8.758M Shares 40,000 Est. Cost $202.38 Unrealized 0.0%

ABBV ABBVIE INC 5.2%

Value $8.323M Shares 94,000 Est. Cost $64.63 Unrealized 0.0%

— MIRATI THERAPEUTICS INC 5.2%

Value $8.247M Shares 64,000 Est. Cost $128.86 Unrealized —

ZBH ZIMMER BIOMET HLDGS INC 5.1%

Value $8.158M Shares 54,500 Est. Cost $131.26 Unrealized 0.0%

ESPR ESPERION THERAPEUTICS INC NE 4.9%

Value $7.776M Shares 130,400 Est. Cost $44.96 Unrealized 0.0%

EW EDWARDS LIFESCIENCES CORP 4.0%

Value $6.299M Shares 27,000 Est. Cost $78.09 Unrealized 0.0%

CI CIGNA CORP NEW 3.9%

Value $6.135M Shares 30,000 Est. Cost $167.70 Unrealized 0.0%

ASND ASCENDIS PHARMA A S 3.7%

Value $5.857M Shares 42,100 Est. Cost $139.12 Unrealized —

— AXONICS MODULATION TECH INC 3.6%

Value $5.764M Shares 208,000 Est. Cost $27.71 Unrealized —

— HORIZON THERAPEUTICS PUB LTD 3.4%

Value $5.43M Shares 150,000 Est. Cost $36.20 Unrealized —

— NEXTCURE INC 3.3%

Value $5.239M Shares 93,000 Est. Cost $56.33 Unrealized —

— CATALENT INC 3.3%

Value $5.18M Shares 92,000 Est. Cost $56.30 Unrealized —

AUPH AURINIA PHARMACEUTICALS INC 3.0%

Value $4.7M Shares 232,000 Est. Cost $9.21 Unrealized 0.0%

— DYNAVAX TECHNOLOGIES CORP 2.8%

Value $4.462M Shares 780,000 Est. Cost $5.72 Unrealized —

— ABEONA THERAPEUTICS INC 2.7%

Value $4.333M Shares 1,325,000 Est. Cost $3.27 Unrealized —

DXCM DEXCOM INC 2.6%

Value $4.156M Shares 19,000 Est. Cost $47.43 Unrealized 0.0%

— MOMENTA PHARMACEUTICALS INC 2.5%

Value $3.946M Shares 200,000 Est. Cost $19.73 Unrealized —

QURE UNIQURE NV 2.5%

Value $3.941M Shares 55,000 Est. Cost $54.91 Unrealized 0.0%

CHRS COHERUS BIOSCIENCES INC 2.4%

Value $3.862M Shares 214,500 Est. Cost $18.44 Unrealized 0.0%

— KADMON HLDGS INC 2.4%

Value $3.76M Shares 830,000 Est. Cost $4.53 Unrealized —

COLL COLLEGIUM PHARMACEUTICAL INC 2.3%

Value $3.704M Shares 180,000 Est. Cost $16.67 Unrealized 0.0%

NBIX NEUROCRINE BIOSCIENCES INC 2.2%

Value $3.547M Shares 33,000 Est. Cost $104.70 Unrealized 0.0%

— IMMUNOMEDICS INC 1.9%

Value $2.962M Shares 140,000 Est. Cost $21.16 Unrealized —

EXAS EXACT SCIENCES CORP 1.8%

Value $2.867M Shares 31,000 Est. Cost $87.91 Unrealized 0.0%

— NEOLEUKIN THERAPEUTICS INC 1.6%

Value $2.587M Shares 210,000 Est. Cost $12.32 Unrealized —

ACAD ACADIA PHARMACEUTICALS INC 1.5%

Value $2.31M Shares 54,000 Est. Cost $43.50 Unrealized 0.0%

MDGL MADRIGAL PHARMACEUTICALS INC 0.9%

Value $1.367M Shares 15,000 Est. Cost $96.98 Unrealized 0.0%

RCKT ROCKET PHARMACEUTICALS INC 0.4%

Value $683K Shares 30,000 Est. Cost $16.70 Unrealized 0.0%

— SUNESIS PHARMACEUTICALS INC 0.3%

Value $473K Shares 1,400,000 Est. Cost $0.34 Unrealized —

— ARAVIVE INC 0.3%

Value $410K Shares 30,000 Est. Cost $13.67 Unrealized —

RLMD RELMADA THERAPEUTICS INC 0.2%

Value $390K Shares 10,000 Est. Cost $28.22 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BAX	BAXTER INTL INC	165,000	$13.8M	8.7%	$73.38	0.0%	COM	071813109
HCA	HCA HEALTHCARE INC	62,700	$9.268M	5.8%	$127.66	0.0%	COM	40412C101
VRTX	VERTEX PHARMACEUTICALS INC	40,000	$8.758M	5.5%	$202.38	0.0%	COM	92532F100
ABBV	ABBVIE INC	94,000	$8.323M	5.2%	$64.63	0.0%	COM	00287Y109
—	MIRATI THERAPEUTICS INC	64,000	$8.247M	5.2%	$128.86	—	COM	60468T105
ZBH	ZIMMER BIOMET HLDGS INC	54,500	$8.158M	5.1%	$131.26	0.0%	COM	98956P102
ESPR	ESPERION THERAPEUTICS INC NE	130,400	$7.776M	4.9%	$44.96	0.0%	COM	29664W105
EW	EDWARDS LIFESCIENCES CORP	27,000	$6.299M	4.0%	$78.09	0.0%	COM	28176E108
CI	CIGNA CORP NEW	30,000	$6.135M	3.9%	$167.70	0.0%	COM	125523100
ASND	ASCENDIS PHARMA A S	42,100	$5.857M	3.7%	$139.12	—	SPONSORED ADR	04351P101
—	AXONICS MODULATION TECH INC	208,000	$5.764M	3.6%	$27.71	—	COM	05465P101
—	HORIZON THERAPEUTICS PUB LTD	150,000	$5.43M	3.4%	$36.20	—	SHS	G46188101
—	NEXTCURE INC	93,000	$5.239M	3.3%	$56.33	—	COM	65343E108
—	CATALENT INC	92,000	$5.18M	3.3%	$56.30	—	COM	148806102
AUPH	AURINIA PHARMACEUTICALS INC	232,000	$4.7M	3.0%	$9.21	0.0%	COM	05156V102
—	DYNAVAX TECHNOLOGIES CORP	780,000	$4.462M	2.8%	$5.72	—	COM NEW	268158201
—	ABEONA THERAPEUTICS INC	1,325,000	$4.333M	2.7%	$3.27	—	COM	00289Y107
DXCM	DEXCOM INC	19,000	$4.156M	2.6%	$47.43	0.0%	COM	252131107
—	MOMENTA PHARMACEUTICALS INC	200,000	$3.946M	2.5%	$19.73	—	COM	60877T100
QURE	UNIQURE NV	55,000	$3.941M	2.5%	$54.91	0.0%	SHS	N90064101
CHRS	COHERUS BIOSCIENCES INC	214,500	$3.862M	2.4%	$18.44	0.0%	COM	19249H103
—	KADMON HLDGS INC	830,000	$3.76M	2.4%	$4.53	—	COM	48283N106
COLL	COLLEGIUM PHARMACEUTICAL INC	180,000	$3.704M	2.3%	$16.67	0.0%	COM	19459J104
NBIX	NEUROCRINE BIOSCIENCES INC	33,000	$3.547M	2.2%	$104.70	0.0%	COM	64125C109
—	IMMUNOMEDICS INC	140,000	$2.962M	1.9%	$21.16	—	COM	452907108
EXAS	EXACT SCIENCES CORP	31,000	$2.867M	1.8%	$87.91	0.0%	COM	30063P105
—	NEOLEUKIN THERAPEUTICS INC	210,000	$2.587M	1.6%	$12.32	—	COM	64049K104
ACAD	ACADIA PHARMACEUTICALS INC	54,000	$2.31M	1.5%	$43.50	0.0%	COM	004225108
MDGL	MADRIGAL PHARMACEUTICALS INC	15,000	$1.367M	0.9%	$96.98	0.0%	COM	558868105
RCKT	ROCKET PHARMACEUTICALS INC	30,000	$683K	0.4%	$16.70	0.0%	COM	77313F106
—	SUNESIS PHARMACEUTICALS INC	1,400,000	$473K	0.3%	$0.34	—	COM	867328700
—	ARAVIVE INC	30,000	$410K	0.3%	$13.67	—	COM	03890D108
RLMD	RELMADA THERAPEUTICS INC	10,000	$390K	0.2%	$28.22	0.0%	COM	75955J402